Induction of endothelial nitric oxide synthase expression by IL-17 in human vascular endothelial cells: Implications for vascular remodeling in transplant vasculopathy

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1544-1550

  Liu, Arthur C ^a   Lee, Martin ^a   McManus, Bruce M ^b,c   Choy, Jonathan C ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; SERINE; SMALL INTERFERING RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INDUCTION; GENE SILENCING; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; TH17 CELL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ARTERIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-17; NITRIC OXIDE SYNTHASE TYPE III; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION; VASCULAR DISEASES;

EID: 84863064387     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102527     Document Type: Article

References (46)

1. Choi, J., D. R. Enis, K. P. Koh, S. L. Shiao, and J. S. Pober. 2004. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683-709. (Pubitemid 38680438)
2. Littman, D. R., and A. Y. Rudensky. 2010. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858.
3. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132. (Pubitemid 41541790)
4. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. (Pubitemid 41541791)
5. Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-567.
6. Roussel, L., F. Houle, C. Chan, Y. Yao, J. Bérubé, R. Olivenstein, J. G. Martin, J. Huot, Q. Hamid, L. Ferri, and S. Rousseau. 2010. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J. Immunol. 184: 4531-4537.
7. Numasaki, M., J. Fukushi, M. Ono, S. K. Narula, P. J. Zavodny, T. Kudo, P. D. Robbins, H. Tahara, and M. T. Lotze. 2003. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627. (Pubitemid 36857622)
8. Palmer, R. M., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526. (Pubitemid 17085822)
9. Pober, J. S., and W. C. Sessa. 2007. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7: 803-815. (Pubitemid 47480307)
10. Mohamed, F., J. C. Monge, A. Gordon, P. Cernacek, D. Blais, and D. J. Stewart. 1995. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler. Thromb. Vasc. Biol. 15: 52-57.
11. Yoshizumi, M., M. A. Perrella, J. C. Burnett, Jr., and M. E. Lee. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209. (Pubitemid 23173071)
12. Rosenkranz-Weiss, P., W. C. Sessa, S. Milstien, S. Kaufman, C. A. Watson, and J. S. Pober. 1994. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest. 93: 2236-2243.
13. Taylor, D. O., L. B. Edwards, M. M. Boucek, E. P. Trulock, D. A. Waltz, B. M. Keck and M. I. Hertz; International Society for Heart and Lung Transplantation. 2006. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J. Heart Lung Transplant. 25: 869-879. (Pubitemid 44143013)
14. Mitchell, R. N., and P. Libby. 2007. Vascular remodeling in transplant vasculopathy. Circ. Res. 100: 967-978. (Pubitemid 46598921)
15. Choy, J. C. 2010. Granzymes and perforin in solid organ transplant rejection. Cell Death Differ. 17: 567-576.
16. De Mey, J. G., P. M. Schiffers, R. H. Hilgers, and M. M. Sanders. 2005. Toward functional genomics of flow-induced outward remodeling of resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 288: H1022-H1027. (Pubitemid 40270002)
17. Herity, N. A., M. R. Ward, S. Lo, and A. C. Yeung. 1999. Review: Clinical aspects of vascular remodeling. J. Cardiovasc. Electrophysiol. 10: 1016-1024. (Pubitemid 29297721)
18. Pethig, K., B. Heublein, T. Wahlers, and A. Haverich; Working Group on Cardiac Allograft Vasculopathy. 1998. Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate vascular remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis. Am. Heart J. 135: 628-633. (Pubitemid 28164898)
19. Hollenberg, S. M., L. W. Klein, J. E. Parrillo, M. Scherer, D. Burns, P. Tamburro, M. Oberoi, M. R. Johnson, and M. R. Costanzo. 2001. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104: 3091-3096. (Pubitemid 34014063)
20. Tang, J. L., V. M. Subbotin, M. A. Antonysamy, A. B. Troutt, A. S. Rao, and A. W. Thomson. 2001. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 72: 348-350.
21. Rao, D. A., R. E. Eid, L. Qin, T. Yi, N. C. Kirkiles-Smith, G. Tellides, and J. S. Pober. 2008. Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J. Exp. Med. 205: 3145-3158.
22. Yuan, X., J. Paez-Cortez, I. Schmitt-Knosalla, F. D'Addio, B. Mfarrej, M. Donnarumma, A. Habicht, M. R. Clarkson, J. Iacomini, L. H. Glimcher, et al. 2008. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J. Exp. Med. 205: 3133-3144.
23. Escalante, N. K., A. von Rossum, M. Lee, and J. C. Choy. 2011. CD155 on human vascular endothelial cells attenuates the acquisition of effector functions in CD8 T cells. Arterioscler. Thromb. Vasc. Biol. 31: 1177-1184.
24. Choy, J. C., Y. Wang, G. Tellides, and J. S. Pober. 2007. Induction of inducible NO synthase in bystander human T cells increases allogeneic responses in the vasculature. Proc. Natl. Acad. Sci. USA 104: 1313-1318. (Pubitemid 46184001)
25. Lin, H., J. E. Wilson, C. R. Roberts, K. J. Horley, G. L. Winters, M. R. Costanzo, and B. M. McManus. 1996. Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis. J. Heart Lung Transplant. 15: 1233-1247. (Pubitemid 26428399)
26. Choy, J. C., A. Kerjner, B. W. Wong, B. M. McManus, and D. J. Granville. 2004. Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts. Am. J. Pathol. 165: 127-133. (Pubitemid 38821820)
27. Choy, J. C., P. C. McDonald, A. C. Suarez, V. H. Hung, J. E. Wilson, B. M. McManus, and D. J. Granville. 2003. Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity. Mod. Pathol. 16: 460-470. (Pubitemid 36618467)
28. Kroll, J., and J. Waltenberger. 1998. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 252: 743-746. (Pubitemid 28556847)
29. Chan, G. C., J. E. Fish, I. A. Mawji, D. D. Leung, A. C. Rachlis, and P. A. Marsden. 2005. Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J. Immunol. 175: 3846-3861. (Pubitemid 41292045)
30. Fulton, D., J. P. Gratton, T. J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T. F. Franke, A. Papapetropoulos, and W. C. Sessa. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601.
31. Shalom-Barak, T., J. Quach, and M. Lotz. 1998. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J. Biol. Chem. 273: 27467-27473. (Pubitemid 28500465)
32. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132: 344-362.
33. Solt, L. A., L. A. Madge, J. S. Orange, and M. J. May. 2007. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta. J. Biol. Chem. 282: 8724-8733. (Pubitemid 47093521)
34. Dumont, O., L. Loufrani, and D. Henrion. 2007. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler. Thromb. Vasc. Biol. 27: 317-324. (Pubitemid 46143046)
35. Kawashima, S., and M. Yokoyama. 2004. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24: 998-1005. (Pubitemid 38737823)
36. Chatterjee, A., S. M. Black, and J. D. Catravas. 2008. Endothelial nitric oxide (NO) and its pathophysiologic regulation. [Published erratum appears in 2009 Vascul. Pharmacol. 50: 208.] Vascul. Pharmacol. 49: 134-140.
37. Krstić, A., V. Ilić, S. Mojsilović, G. Jovcić, P. Milenković, and D. Bugarski. 2009. p38 MAPK signaling mediates IL-17-induced nitric oxide synthase expression in bone marrow cells. Growth Factors 27: 79-90.
38. Davis, M. E., I. M. Grumbach, T. Fukai, A. Cutchins, and D. G. Harrison. 2004. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. J. Biol. Chem. 279: 163-168. (Pubitemid 38044811)
39. Zhang, R., W. Min, and W. C. Sessa. 1995. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J. Biol. Chem. 270: 15320-15326.
40. Rubin, J., T. C. Murphy, L. Zhu, E. Roy, M. S. Nanes, and X. Fan. 2003. Mechanical strain differentially regulates endothelial nitric-oxide synthase and receptor activator of nuclear kappa B ligand expression via ERK1/2 MAPK. J. Biol. Chem. 278: 34018-34025. (Pubitemid 37553238)
41. Xing, F., J. Liu, Y. Mo, Z. Liu, Q. Qin, J. Wang, Z. Fan, Y. Long, N. Liu, K. Zhao, and Y. Jiang. 2009. Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway. J. Cell. Mol. Med. 13: 1136-1148.
42. Anderson, H. D., D. Rahmutula, and D. G. Gardner. 2004. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J. Biol. Chem. 279: 963-969. (Pubitemid 38082617)
43. Ruddy, M. J., G. C.Wong, X. K. Liu, H. Yamamoto, S. Kasayama, K. L. Kirkwood, and S. L. Gaffen. 2004. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J. Biol. Chem. 279: 2559-2567. (Pubitemid 38114241)
44. Koh, K. P., Y. Wang, T. Yi, S. L. Shiao, M. I. Lorber, W. C. Sessa, G. Tellides, and J. S. Pober. 2004. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J. Clin. Invest. 114: 846-856. (Pubitemid 39578744)
45. Rudic, R. D., E. G. Shesely, N. Maeda, O. Smithies, S. S. Segal, and W. C. Sessa. 1998. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101: 731-736. (Pubitemid 28096068)
46. Madhur, M. S., S. A. Funt, L. Li, A. Vinh, W. Chen, H. E. Lob, Y. Iwakura, Y. Blinder, A. Rahman, A. A. Quyyumi, and D. G. Harrison. 2011. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31: 1565-1572.